Release Date: 01/08/19 09:39 Summary: Capital Raising and Potential Merger Price Sensitive: Yes Download Document 218.17KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%